HUTCHMED (China) (HCM) Gains from Investment Securities (2018 - 2021)
HUTCHMED (China) (HCM) posted quarterly Gains from Investment Securities of $11.5 million for Q2 2021, up 63.64% year-over-year from $7.1 million in Q2 2020, and down 62.19% quarter-over-quarter from $30.5 million in Q1 2021.
HUTCHMED (China) (HCM) Gains from Investment Securities (2018 - 2021) Analysis & Trends
HUTCHMED (China) (HCM) has reported Gains from Investment Securities for 4 consecutive years, with $11.5 million the latest figure, recorded in Q2 2021.
- In Q2 2021, Gains from Investment Securities rose 63.64% year-over-year to $11.5 million; the TTM figure through Jun 2021 stood at $77.4 million (up 70.86% YoY), while the FY2025 annual figure was $7.0 million, down 80.0% from the prior year.
- Gains from Investment Securities slipped to $11.5 million in Q2 2021 per HCM's latest filing, from $30.5 million in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $30.5 million in Q1 2021 and bottomed at $7.1 million in Q2 2020.
- Historically, Gains from Investment Securities has averaged $16.5 million across 4 years, with a median of $11.6 million in 2018.
- Annual changes were most pronounced in 2019 — Gains from Investment Securities decreased 14.8% — and 2021, when it surged 63.64%.
- HUTCHMED (China)'s Gains from Investment Securities stood at $11.7 million in 2018, then decreased by 14.8% to $10.0 million in 2019, then slipped by 29.22% to $7.1 million in 2020, then jumped by 63.64% to $11.5 million in 2021.
- Business Quant data shows HCM's Gains from Investment Securities at $11.5 million in Q2 2021, $30.5 million in Q1 2021, and $7.1 million in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | HUTCHMED (China) | 2.18 Bn | 2.18 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 11.54 Mn |
| Jun 30, 2021 | 11.54 Mn |
| Mar 31, 2021 | 30.51 Mn |
| Mar 31, 2021 | 30.51 Mn |
| Jun 30, 2020 | 7.05 Mn |
| Jun 30, 2020 | 7.05 Mn |
| Mar 31, 2020 | 28.27 Mn |
| Mar 31, 2020 | 28.27 Mn |
| Dec 31, 2019 | 9.96 Mn |
| Dec 31, 2019 | 9.96 Mn |
| Dec 31, 2018 | 11.69 Mn |
| Dec 31, 2018 | 11.69 Mn |